BG50834A3 - Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides - Google Patents

Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides

Info

Publication number
BG50834A3
BG50834A3 BG090022A BG9002289A BG50834A3 BG 50834 A3 BG50834 A3 BG 50834A3 BG 090022 A BG090022 A BG 090022A BG 9002289 A BG9002289 A BG 9002289A BG 50834 A3 BG50834 A3 BG 50834A3
Authority
BG
Bulgaria
Prior art keywords
oxindole
carboxamides
acyl
preparation
general formula
Prior art date
Application number
BG090022A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Crawford
Lawrence Reiter
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG50834A3 publication Critical patent/BG50834A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG090022A 1988-10-18 1989-10-16 Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides BG50834A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/003658 WO1990004393A1 (en) 1988-10-18 1988-10-18 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (1)

Publication Number Publication Date
BG50834A3 true BG50834A3 (en) 1992-11-16

Family

ID=22208957

Family Applications (1)

Application Number Title Priority Date Filing Date
BG090022A BG50834A3 (en) 1988-10-18 1989-10-16 Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides

Country Status (33)

Country Link
US (1) US5118703A (de)
JP (1) JPH07597B2 (de)
KR (1) KR910007237B1 (de)
CN (1) CN1022241C (de)
AP (1) AP118A (de)
AR (1) AR246519A1 (de)
AT (1) ATE125794T1 (de)
AU (1) AU606819B2 (de)
BG (1) BG50834A3 (de)
CA (1) CA1339558C (de)
CZ (1) CZ278983B6 (de)
DD (1) DD285604A5 (de)
DK (1) DK514989A (de)
EG (1) EG19887A (de)
FI (1) FI95253C (de)
HU (1) HU208421B (de)
IE (1) IE66586B1 (de)
IL (1) IL91960A (de)
IS (1) IS1598B (de)
MA (1) MA21657A1 (de)
MX (1) MX18021A (de)
MY (1) MY104238A (de)
NO (1) NO178027C (de)
NZ (1) NZ231044A (de)
OA (1) OA09140A (de)
PH (1) PH27554A (de)
PL (2) PL163112B1 (de)
PT (1) PT92000B (de)
RO (1) RO109195B1 (de)
RU (1) RU2036905C1 (de)
SK (1) SK278175B6 (de)
WO (1) WO1990004393A1 (de)
YU (1) YU48070B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
DE69306595T2 (de) * 1992-11-23 1997-04-03 Pfizer Regioselektive synthese von 4-chlor-2-thiophencarbonsäure
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
CA2155664C (en) * 1993-02-09 1999-06-15 Ralph P. Robinson Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
CN1094819C (zh) * 1997-04-30 2002-11-27 大兴株式会社 环状坯料之制造装置
EP0984012A3 (de) * 1998-08-31 2001-01-10 Pfizer Products Inc. Stickstoffmonoxid freisetzende Oxindol-Prodrugs mit analgetischen und entzündungshemmenden Eigenschaften
MXPA02004010A (es) * 1999-10-26 2002-10-23 Univ Texas Southwestern Med Ct Metodos para tratamiento de perdida capilar que consisten en administrar compuesto de indolina.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE558210A (de) * 1956-06-08
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3923996A (en) * 1972-07-31 1975-12-02 Sandoz Ag 3-Substituted-oxindoles in compositions and methods of treating obesity
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
DE3268971D1 (en) * 1981-10-06 1986-03-20 Ici Plc Biochemical process
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
EP0365194B1 (de) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
IE66586B1 (en) 1996-01-24
NO911512D0 (no) 1991-04-17
AU4295689A (en) 1990-04-26
SK590689A3 (en) 1996-03-06
HU208421B (en) 1993-10-28
CZ590689A3 (en) 1994-04-13
IS1598B (is) 1996-05-20
CZ278983B6 (en) 1994-11-16
NO178027C (no) 1996-01-10
JPH07597B2 (ja) 1995-01-11
DK514989A (da) 1990-04-19
MA21657A1 (fr) 1990-07-01
NZ231044A (en) 1990-12-21
PH27554A (en) 1993-08-18
EG19887A (en) 1996-03-31
KR910007237B1 (ko) 1991-09-24
SK278175B6 (en) 1996-03-06
ATE125794T1 (de) 1995-08-15
DD285604A5 (de) 1990-12-19
FI95253B (fi) 1995-09-29
AR246519A1 (es) 1994-08-31
PL163112B1 (pl) 1994-02-28
RO109195B1 (ro) 1994-12-30
AP8900141A0 (en) 1989-10-31
OA09140A (fr) 1991-10-31
PT92000B (pt) 1995-06-30
NO911512L (no) 1991-06-12
CN1022241C (zh) 1993-09-29
CA1339558C (en) 1997-11-25
JPH02149559A (ja) 1990-06-08
IE893332L (en) 1990-04-18
FI95253C (fi) 1996-01-10
IL91960A (en) 1994-04-12
AU606819B2 (en) 1991-02-14
MX18021A (es) 1993-11-01
FI911855A0 (fi) 1991-04-17
HUT58052A (en) 1992-01-28
HU886740D0 (en) 1991-07-29
WO1990004393A1 (en) 1990-05-03
US5118703A (en) 1992-06-02
PT92000A (pt) 1990-04-30
YU200589A (en) 1991-02-28
MY104238A (en) 1994-02-28
NO178027B (no) 1995-10-02
IL91960A0 (en) 1990-07-12
DK514989D0 (da) 1989-10-17
YU48070B (sh) 1997-01-08
AP118A (en) 1991-02-22
PL162316B1 (pl) 1993-09-30
RU2036905C1 (ru) 1995-06-09
CN1041938A (zh) 1990-05-09
IS3509A7 (is) 1990-04-19
KR900006285A (ko) 1990-05-07

Similar Documents

Publication Publication Date Title
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
ES553821A0 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
FI90976C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi
DK588486D0 (da) Anvendelse af en forbindelse til behandling af hypoxi
FI850654L (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
ES555646A0 (es) Un procedimiento para producir derivados de 4-0-sulfonil-uracilo
NO874699D0 (no) Fremgangsmaate for frenstilling av nye substituerte cefalosporin-sulfoner.
BG44204A3 (en) Method for preparing of 2- oxyindol derivatives
BG50834A3 (en) Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
FI861821A0 (fi) Nytt foerfarande foer optisk separation av racemiska blandningar av -naftylpropionsyror
DK45486D0 (da) Anti-inflammatorisk praeparat
ES2045197T3 (es) N-substituidos-n-nitroso-aminoacetonitrilos, procedimiento para su fabricacion y utilizacion.
FI863471A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
FR2338707A1 (fr) Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
ES8606329A1 (es) Procedimiento para preparar derivados de tiofeno
FI893434A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
IT8647634A0 (it) Procedimento di preparazione di una fenilurea sostituita
ES458237A1 (es) Un procedimiento para la preparacion de nuevas iminas.
IT1208240B (it) Dispositivo per la preparazione di una miscela combustibile
DK630386D0 (da) Reflektor til anvendelse til ensartet belysning af et polygonalt omraade